Current best practices and rationalistic perspectives in causation-based prevention, early detection and multidisciplinary treatment of breast and gastric cancer

Gastric & Breast Cancer e-journal
DOI: 10.2122/gbc.2012.0243


Tyrosine kinase inhibitors expand indications for surgical resection of advanced GIST.

Prof. Theodore Liakakos, MD, PhD

Affiliation: Theodore Liakakos, MD, Professor of Surgery, 3rd Department of Surgery, University of Athens, School of Medicine, Attikon University Hospital, Rimini 1, Chaidari, Athens 12462, Greece.


Since there is no abstract available we provide the first paragraph
Imatinib, a small-molecule selective tyrosine-kinase inhibitor, is associated with high responsiveness in patients with gastrointestinal stromal tumors and it has been the standard adjuvant systemic treatment after tumor resection. This efficacy raises the question of laparoscopic surgery also in the treatment of locally advanced or metastatic GIST.

(Citation: Gastric & Breast Cancer 2011; 11(4): 233-235)

You can have an online full-text access and a PDF of this article:
  • Either purchase this paper for €35 EUR. Please, click here
Please specify DOI of article
  • Or through one year subscription PayPal

Online ISSN : 1109 - 7647
Print ISSN : 1109 - 7655

We subscribe to the HONcode principles of the HON Foundation. Click to verify. We subscribe to the HONcode principles. Verify here.
please, read our policy about privacy and confidentiality of information and transparency of sponsorship

last update: 31 October 2012